Medico Remedies Ltd

Medico Remedies Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company's equity shares will be closed for all Insiders, Designated Persons and their immediate relatives from October 1, 2026, up to 48 hours after the declaration of the Unaudited Financial Results for the quarter ended September 30, 2026.

Gillanders Arbuthnot & Company Ltd, Bharat Immunological & Biological Corporation Ltd, Growington Ventures India Ltd and Arman Financial Services Ltd are among the other losers in the BSE's 'B' group today, 28 September 2026.Medico Remedies Ltd tumbled 14.84% to Rs 22.26 at 14:33 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 3.42 lakh shares were traded on the counter so far as against the average daily volumes of 39339 shares in the past one month.Gillanders Arbuthnot & Company Ltd lost 12.83% to Rs 107. The stock was the second biggest loser in 'B' group.On the BSE, 2134 shares were traded on the counter so far as against the average daily volumes of 355 shares in the past one month.Bharat Immunological & Biological Corporation Ltd crashed 12.38% to Rs 11.4. The stock was the third biggest loser in 'B' group.On the BSE, 2.8 lakh shares were traded on the counter so far as against the average daily volumes of 24634 shares in the past one month.Growington Ventures India Ltd dropped 12.09% to Rs 0.8. The stock was the fourth biggest loser in 'B' group.On the BSE, 89.34 lakh shares were traded on the counter so far as against the average daily volumes of 81.63 lakh shares in the past one month.Arman Financial Services Ltd shed 9.90% to Rs 1704.75. The stock was the fifth biggest loser in 'B' group.On the BSE, 9627 shares were traded on the counter so far as against the average daily volumes of 1572 shares in the past one month.

Turtlemint Fintech Solutions Ltd, Aastha Spintex Ltd, Manugraph India Ltd and Atal Realtech Ltd are among the other losers in the BSE's 'B' group today, 25 September 2026.Medico Remedies Ltd tumbled 19.99% to Rs 26.14 at 14:32 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 2.86 lakh shares were traded on the counter so far as against the average daily volumes of 21879 shares in the past one month.Turtlemint Fintech Solutions Ltd crashed 19.98% to Rs 87.3. The stock was the second biggest loser in 'B' group.On the BSE, 15 lakh shares were traded on the counter so far as against the average daily volumes of 1.08 lakh shares in the past one month.Aastha Spintex Ltd lost 10.00% to Rs 72.74. The stock was the third biggest loser in 'B' group.On the BSE, 2.51 lakh shares were traded on the counter so far as against the average daily volumes of 1.44 lakh shares in the past one month.Manugraph India Ltd plummeted 9.98% to Rs 19.93. The stock was the fourth biggest loser in 'B' group.On the BSE, 28908 shares were traded on the counter so far as against the average daily volumes of 20345 shares in the past one month.Atal Realtech Ltd dropped 9.58% to Rs 13.22. The stock was the fifth biggest loser in 'B' group.On the BSE, 3.19 lakh shares were traded on the counter so far as against the average daily volumes of 9.19 lakh shares in the past one month.

Medico Remedies Limited informed the BSE Limited and National Stock Exchange of India Limited that the register of members and share transfer book will be closed from Wednesday, September 16, 2026, to Tuesday, September 22, 2026, for the 32nd Annual General Meeting scheduled on Tuesday, September 22, 2026.

Medico Remedies Limited will hold a board meeting on Thursday, August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report thereon.

Medico Remedies Ltd. announced it has secured a government supply order worth USD 1406450 (approximately Rs 13.38 Crores) from PROMESE/CAL, the Dominican Republic's centralized medicine and health supplies program, to supply tablets, capsules, and dry syrups. The order, awarded by an international entity, requires Medico Remedies Ltd. to complete the supply within 3 months, and does not involve any related party transactions.

Net profit of Medico Remedies rose 35.02% to Rs 5.86 crore in the quarter ended March 2026 as against Rs 4.34 crore during the previous quarter ended March 2025. Sales rose 37.55% to Rs 56.81 crore in the quarter ended March 2026 as against Rs 41.30 crore during the previous quarter ended March 2025. For the full year,net profit rose 30.03% to Rs 13.12 crore in the year ended March 2026 as against Rs 10.09 crore during the previous year ended March 2025. Sales rose 36.73% to Rs 206.38 crore in the year ended March 2026 as against Rs 150.94 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales56.8141.30 38 206.38150.94 37 OPM %12.6016.15 -8.269.94 - PBDT9.136.47 41 21.1616.53 28 PBT8.335.70 46 18.0713.50 34 NP5.864.34 35 13.1210.09 30 Powered by Capital Market - Live

Medico Remedies will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Net profit of Medico Remedies rose 9.54% to Rs 2.87 crore in the quarter ended December 2025 as against Rs 2.62 crore during the previous quarter ended December 2024. Sales rose 48.59% to Rs 58.68 crore in the quarter ended December 2025 as against Rs 39.49 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales58.6839.49 49 OPM %7.387.88 - PBDT4.624.26 8 PBT3.833.50 9 NP2.872.62 10 Powered by Capital Market - Live

Medico Remedies will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live